Results 351 to 360 of about 238,098 (403)
Some of the next articles are maybe not open access.
2023
Inflammation and coagulation are tightly connected, whereby an inflammatory host response will activate coagulation, resulting in a spectrum of coagulopathies that range from a mildly decreased platelet count to disseminated intravascular coagulation (DIC).
Dujardin, Romein W.G. +2 more
openaire +4 more sources
Inflammation and coagulation are tightly connected, whereby an inflammatory host response will activate coagulation, resulting in a spectrum of coagulopathies that range from a mildly decreased platelet count to disseminated intravascular coagulation (DIC).
Dujardin, Romein W.G. +2 more
openaire +4 more sources
Small, 2021
The inevitable bleeding during tumor resection greatly increases the risk of tumor recurrence caused by metastasis of cancer cells with blood, and hemostasis and prevention of post-operation tumor recurrence is still a challenge.
Yongping Liang +3 more
semanticscholar +1 more source
The inevitable bleeding during tumor resection greatly increases the risk of tumor recurrence caused by metastasis of cancer cells with blood, and hemostasis and prevention of post-operation tumor recurrence is still a challenge.
Yongping Liang +3 more
semanticscholar +1 more source
Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis
Arteriosclerosis, Thrombosis and Vascular Biology, 2018Tissue factor (TF) is the high-affinity receptor and cofactor for factor (F)VII/VIIa. The TF-FVIIa complex is the primary initiator of blood coagulation and plays an essential role in hemostasis. TF is expressed on perivascular cells and epithelial cells
S. Grover, N. Mackman
semanticscholar +1 more source
Thrombin: A Pivotal Player in Hemostasis and Beyond
Seminars in Thrombosis and Hemostasis, 2021The serine protease thrombin, a naturally derived enzyme, plays a key role in hemostasis by converting fibrinogen to fibrin and activating coagulation factor XIII whereby the fibrin clot is stabilized.
J. Larsen, A. Hvas
semanticscholar +1 more source
American Journal of Hematology, 1990
AbstractHemostatic abnormalities are present in a majority of patients with metastatic cancer. These abnormalities can be categorized as 1) increased platelet aggregation and activation, 2) abnormal activation of coagulation cascade, 3) release of plasminogen activator, and 4) decreased hepatic synthesis of anticoagulant proteins like Protein C and ...
Harry L. Messmore, Sucha Nand
openaire +3 more sources
AbstractHemostatic abnormalities are present in a majority of patients with metastatic cancer. These abnormalities can be categorized as 1) increased platelet aggregation and activation, 2) abnormal activation of coagulation cascade, 3) release of plasminogen activator, and 4) decreased hepatic synthesis of anticoagulant proteins like Protein C and ...
Harry L. Messmore, Sucha Nand
openaire +3 more sources
Blood Coagulation & Fibrinolysis, 2022
The breakdown of vascular integrity triggers a series of reactions, initially involving a vasoconstriction phenomenon that reduces blood loss and leads to platelet plug formation under changing flow conditions. Once the platelet plug has formed, the coagulation system is activated in order to allow the formation of fibrin ...
Cristina, Sierra +2 more
openaire +2 more sources
The breakdown of vascular integrity triggers a series of reactions, initially involving a vasoconstriction phenomenon that reduces blood loss and leads to platelet plug formation under changing flow conditions. Once the platelet plug has formed, the coagulation system is activated in order to allow the formation of fibrin ...
Cristina, Sierra +2 more
openaire +2 more sources
2017
Hemostasis is the process that stops blood loss from a damaged vessel. Blood clotting is achieved by a cascade of enzymatic reactions, which involves a series of factors. Among them are the zymogens prekallikrein, prothrombin, factors VII, IX, X, XI, and XII, which are converted to active proteases by hydrolysis.
Antonio Blanco, Gustavo Blanco
openaire +2 more sources
Hemostasis is the process that stops blood loss from a damaged vessel. Blood clotting is achieved by a cascade of enzymatic reactions, which involves a series of factors. Among them are the zymogens prekallikrein, prothrombin, factors VII, IX, X, XI, and XII, which are converted to active proteases by hydrolysis.
Antonio Blanco, Gustavo Blanco
openaire +2 more sources
ACS Applied Materials and Interfaces, 2019
The development of biodegradable and antibacterial hemostatic materials with high blood absorption to halt the internal hemorrhage of deep non-compressible wounds remains a challenge.
Haibin Yuan, Lin Chen, Feng F. Hong
semanticscholar +1 more source
The development of biodegradable and antibacterial hemostatic materials with high blood absorption to halt the internal hemorrhage of deep non-compressible wounds remains a challenge.
Haibin Yuan, Lin Chen, Feng F. Hong
semanticscholar +1 more source
Tetra‐PEG Based Hydrogel Sealants for In Vivo Visceral Hemostasis
Advances in Materials, 2019Medical sealant devices for in vivo hemostasis are far from satisfactory in the aged society. A major challenge is effective integration of quick hemorrhage control of the increased anticoagulated patients, high safety, and facile accessibility.
Yazhong Bu +7 more
semanticscholar +1 more source